One of the crucial steps in tumor growth and metastasis is proteolytic modification of the extracellular matrix surrounding tumor cells. A major class of proteases that mediates this process is the matrix metalloproteinases (MMPs); inhibition of these enzymes has been shown to prevent tumor progression. Although it was originally thought that tumor MMPs were produced by tumor cells themselves, it is now clear that, in vivo, most tumor MMPs are produced by stromal cells associated with tumors. The tumor cell surface glycoprotein, EMMPRIN, stimulates production of several MMPs by fibroblasts and endothelial cells. Also, EMMPRIN is enriched in malignant tumors relative to normal tissues and elevated expression of EMMPRIN leads to increased tumor growth in vivo. Thus EMMPRIN may be an important regulator of MMP production that serves a crucial role in cancer. Consequently, the focus of this proposal will be the structure, function and mechanism of action of EMMPRIN in tumorigenesis. The role of EMMPRIN in various aspects of tumor progression will be tested by overexpression, by antisense inhibition of expression, and by testing susceptibility of EMMPRIN-null mice to tumor growth. The potential significance of EMMPRIN stimulation of endothelial MMP production in augmenting tumor angiogenesis, and of EMMPRIN stimulation of fibroblast MMP production in tumor cell growth and invasiveness will be explored. The fibroblast/endothelial cell receptor responsible for transduction of EMMPRIN stimulation of MMP production will be isolated and characterized. Finally, the region of EMMPRIN responsible for interacting with stromal cells and stimulating MMP production will be mapped, and reagents will be designed to facilitate examination of the functions of EMMPRIN and is putative receptor. The results obtained should determine definitively whether or not EMMPRIN is a crucial element in malignancy, and they should begin to resolve the mechanisms whereby its action is regulated and transmitted. Interference with EMMPRIN action may then be an effective way to inhibit tumor progression patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
7R01CA079866-05
Application #
6784432
Study Section
Pathology B Study Section (PTHB)
Program Officer
Sathyamoorthy, Neeraja
Project Start
2000-06-15
Project End
2005-05-31
Budget Start
2003-07-01
Budget End
2004-05-31
Support Year
5
Fiscal Year
2003
Total Cost
$279,651
Indirect Cost
Name
Medical University of South Carolina
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29425
Hasaneen, Nadia A; Zucker, Stanley; Lin, Richard Z et al. (2007) Angiogenesis is induced by airway smooth muscle strain. Am J Physiol Lung Cell Mol Physiol 293:L1059-68
Ghatak, Shibnath; Misra, Suniti; Toole, Bryan P (2005) Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. J Biol Chem 280:8875-83
Yan, Li; Zucker, Stanley; Toole, Bryan P (2005) Roles of the multifunctional glycoprotein, emmprin (basigin; CD147), in tumour progression. Thromb Haemost 93:199-204
Hasaneen, Nadia A; Zucker, Stanley; Cao, Jian et al. (2005) Cyclic mechanical strain-induced proliferation and migration of human airway smooth muscle cells: role of EMMPRIN and MMPs. FASEB J 19:1507-9
Zucker, Stanley; Vacirca, Jeffrey (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23:101-17
Marieb, Erica A; Zoltan-Jones, Alexandra; Li, Rongsong et al. (2004) Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production. Cancer Res 64:1229-32
Misra, Suniti; Ghatak, Shibnath; Zoltan-Jones, Alexandra et al. (2003) Regulation of multidrug resistance in cancer cells by hyaluronan. J Biol Chem 278:25285-8
Pavlaki, Maria; Zucker, Stanley (2003) Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials. Cancer Metastasis Rev 22:177-203
Caudroy, Stephanie; Polette, Myriam; Nawrocki-Raby, Beatrice et al. (2002) EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin Exp Metastasis 19:697-702
Li, R; Huang, L; Guo, H et al. (2001) Basigin (murine EMMPRIN) stimulates matrix metalloproteinase production by fibroblasts. J Cell Physiol 186:371-9

Showing the most recent 10 out of 11 publications